PNC Financial Services Group
GNOM icon

PNC Financial Services Group’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

PNC Financial Services Group’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.5K Hold
554
– – ﹤0.01% 3575
2026
Q1 		$24.2K Hold
554
– – ﹤0.01% 3603
2025
Q4 		$25.2K Hold
554
– – ﹤0.01% 3561
2025
Q3 		$21.5K Sell
554
-1
-0.2% -$36 ﹤0.01% 3600
2025
Q2 		$18.7K Sell
555
-60
-10% -$1.9K ﹤0.01% 3603
2025
Q1 		$19.6K Hold
615
– – ﹤0.01% 3550
2024
Q4 		$23.9K Sell
615
-926
-60% -$38.9K ﹤0.01% 3445
2024
Q3 		$69.4K Sell
1,541
-14
-0.9% -$626 ﹤0.01% 2892
2024
Q2 		$64.9K Hold
1,555
– – ﹤0.01% 2894
2024
Q1 		$70.8K Hold
1,555
– – ﹤0.01% 2805
2023
Q4 		$71.9K Hold
1,555
– – ﹤0.01% 2787
2023
Q3 		$63.3K Sell
1,555
-63
-4% -$2.87K ﹤0.01% 2826
2023
Q2 		$78.4K Hold
1,618
– – ﹤0.01% 2788
2023
Q1 		$79.7K Sell
1,618
-81
-5% -$4.17K ﹤0.01% 2708
2022
Q4 		$86K Sell
1,699
-113
-6% -$5.83K ﹤0.01% 2667
2022
Q3 		$91K Sell
1,812
-196,332
-99% -$11.1M ﹤0.01% 2597
2022
Q2 		$9.68M Sell
198,144
-7,799
-4% -$395K 0.01% 494
2022
Q1 		$12.4M Sell
205,943
-23,491
-10% -$1.48M 0.01% 475
2021
Q4 		$18.2M Sell
229,434
-15,888
-6% -$1.33M 0.02% 428
2021
Q3 		$21.7M Buy
245,322
+14,555
+6% +$1.36M 0.02% 375
2021
Q2 		$23M Buy
230,767
+35,666
+18% +$3.16M 0.02% 373
2021
Q1 		$17.5M Buy
195,101
+19,220
+11% +$1.9M 0.02% 401
2020
Q4 		$16.6M Buy
175,881
+19,226
+12% +$1.61M 0.02% 394
2020
Q3 		$11.3M Buy
156,655
+22,319
+17% +$1.6M 0.01% 433
2020
Q2 		$9.44M Buy
+134,336
New +$8.37M 0.01% 456

Other funds holding GNOM

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return
CFD
Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $9.72B AUM 29.41% 1-Year Est. Return

PNC Financial Services Group's GNOM Position: Q2 2026 in Review

PNC Financial Services Group held its Global X Genomics & Biotechnology ETF (GNOM) position steady in Q2 2026 at 554 shares worth $31.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3575.

PNC Financial Services Group first reported a position in GNOM in Q2 2020 and has held it in 25 quarters since. The position peaked at $23M in Q2 2021. 48 funds tracked by Wall St. Rank hold GNOM as of Q2 2026.

  • PNC Financial Services Group held 554 shares of Global X Genomics & Biotechnology ETF worth $31.5K as of Q2 2026.
  • PNC Financial Services Group left its Global X Genomics & Biotechnology ETF share count unchanged in Q2 2026.
  • Global X Genomics & Biotechnology ETF made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3575 holding.
  • PNC Financial Services Group first reported a position in Global X Genomics & Biotechnology ETF in Q2 2020 and has held it in 25 quarters since.
  • PNC Financial Services Group's Global X Genomics & Biotechnology ETF position peaked at $23M in Q2 2021.
  • 48 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.